Page last updated: 2024-08-17

adenosine monophosphate and Blood Loss, Postoperative

adenosine monophosphate has been researched along with Blood Loss, Postoperative in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hollis, IB; Newsome, AS; Van Tuyl, JS1
Angiolillo, DJ; Brtko, M; Cannon, LA; Chandna, H; Chronos, N; Dietrich, M; Dyke, CM; Firstenberg, MS; Holmes, DR; Hutyra, M; Liu, T; Manoukian, SV; Montalescot, G; Prats, J; Price, M; Ramaiahm, C; Todd, M; Topo, EJ; Tummala, P; Voeltz, M; Welsby, I1
Angiolillo, DJ; Brtko, M; Cannon, L; Chandna, H; Dyke, C; Firstenberg, MS; Hutyra, M; Liu, T; Manoukian, SV; Montalescot, G; Prats, J; Price, MJ; Ramaiah, C; Topol, EJ; Tummala, PE; Voeltz, MD; Welsby, IJ1

Reviews

1 review(s) available for adenosine monophosphate and Blood Loss, Postoperative

ArticleYear
Perioperative Bridging With Glycoprotein IIb/IIIa Inhibitors Versus Cangrelor: Balancing Efficacy and Safety.
    The Annals of pharmacotherapy, 2019, Volume: 53, Issue:7

    Topics: Adenosine Monophosphate; Cardiovascular Surgical Procedures; Humans; Injections, Intravenous; Male; Middle Aged; Perioperative Care; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Postoperative Hemorrhage; Practice Guidelines as Topic; Treatment Outcome

2019

Trials

2 trial(s) available for adenosine monophosphate and Blood Loss, Postoperative

ArticleYear
Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery.
    The heart surgery forum, 2013, Volume: 16, Issue:2

    Topics: Adenosine Monophosphate; Administration, Oral; Adult; Aged; Aged, 80 and over; Blood Transfusion; Coronary Artery Bypass; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Injections, Intravenous; Male; Middle Aged; Placebo Effect; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Premedication; Prevalence; Purinergic P2Y Receptor Antagonists; Pyridines; Risk Assessment; Treatment Outcome; United States

2013
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial.
    JAMA, 2012, Jan-18, Volume: 307, Issue:3

    Topics: Acute Coronary Syndrome; Adenosine Monophosphate; Adult; Aged; Aged, 80 and over; Blood Loss, Surgical; Coronary Artery Bypass; Coronary Artery Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Purinergic P2Y Receptor Antagonists; Stents; Thienopyridines; Thrombosis

2012